… to ischemic heart disease and subsequent acute myocardial infarction and heart failure, …
by various sources (NADPH oxidases, xanthine oxidase and mitochondrial resperatory chain) …

… diseases, and chronic heart failure (11-14). XO inhibitors can also decrease the expression
of … In contrast, FBX cotreatment inhibited the increased expression of these NADPH oxidase …

… mechanism of the relationship between xanthine oxidase (XO) activity and obesity has not
… In line with this, an increased expression and activity of XO was observed in adipose tissue …

… frequent hypotensions, coronary heart disease, and cardiac heart failure are other difficult to
… diabetes like the second cause of arteriovenous fistulas failure, after the age of patients so …

… Those excluded include subjects on immune suppressive drugs, those with malignancies,
gouty arthritis, heart failure, renal failure and those on uric acid lowering drugs. 5.0 ml of …

… While the enzymatic activity of PON1 in the cardiac tissue significantly increased after oral
… In contrast, the specific activity of the cardiac XO noted a significant reduction in the propolis …

… The modulation of xanthine oxidase (XO) activity is critical to the treatment of hyperuricemia
and oxidative stress-related disease. Although the walnut protein hydrolysates had been …

… In the present study, we investigated the effects of xanthine oxidase (XO) inhibition on …
that XO activity was associated with oxidative stress markers and increased expression of …

… in the activity of xanthine oxidoreductase, but further studies are needed. Xanthine oxidase
inhibition consistently … In heart failure patients with or without hyperuricemia, allopurinol …

… activity of superoxide dismutase and catalase. IN last years it was found that with an increase
in the activity of xanthine oxidase, the activity … At the European Congress on Heart Failure …